Icelandic-founded biotech developing lipid nanoparticle delivery systems for RNA-based therapeutics, now headquartered in Boston.
| Date | Round | Amount |
|---|---|---|
| Aug 2025 | Seed Axelyf raised a $2.6 million seed led by Brunnur Ventures, with an extension expected up to $4.1 million, for its lipid nanoparticles for RNA therapies. | $2.6M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.